Evrysdi
NICE reaches a deal with Roche on access to oral SMA drug Evrysdi
Phil Taylor
Evrysdi, NHS, NICE, Risdiplam, Roche, spinal muscular atrophy
0 Comment
X
NICE reaches a deal with Roche on access to oral SMA drug Evrysdi
https://pharmaphorum.com/news/nice-reaches-a-deal-with-roche-on-access-to-oral-sma-drug-evrysdi/
Roche builds evidence for Evrysdi’s benefits in younger SMA patients
Phil Taylor
Biogen, Evrysdi, Novartis, Roche, spinal muscular atrophy, Spinraza, Zolgensma
0 Comment
X
Roche builds evidence for Evrysdi’s benefits in younger SMA patients
https://pharmaphorum.com/news/roche-builds-evidence-for-evrysdis-benefits-younger-sma-patients/
NICE ‘no’ to Roche’s risdiplam for SMA not unexpected, says patient group
Phil Taylor
Evrysdi, HEOR, NICE, Risdiplam, Roche, spinal muscular atrophy
0 Comment
X
NICE ‘no’ to Roche’s risdiplam for SMA not unexpected, says patient group
https://pharmaphorum.com/news/nice-no-to-roches-risdiplam-for-sma-not-unexpected-says-patient-group/
Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
Richard Staines
Evrysdi, Rare diseases, Roche, SMA
0 Comment
X
Evrysdi has ‘real world impact’ on lives of babies with severe SMA, says Roche
https://pharmaphorum.com/news/evrysdi-has-real-world-impact-on-lives-of-babies-with-severe-sma-says-roche/